Hemodialysis International

Cover image for Vol. 22 Issue 1

Edited By: John Daugirdas

Impact Factor: 1.353

ISI Journal Citation Reports © Ranking: 2016: 57/77 (Urology & Nephrology)

Online ISSN: 1542-4758

Author Guidelines

Author Services
Resources for authors can be found at Wiley's Author Services website: http://authorservices.wiley.com/bauthor/

Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to Pub-Med Central upon acceptance. The accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.

Online Open
We offer OnlineOpen to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. For information on Online Open and Wiley's Open Access publishing options for authors, please click here.

Author Guidelines

Editorial Overview

Hemodialysis International is an official publication of the International Society for Hemodialysis. There are four quarterly issues: January, April, July, and October. The annual fall supplement, published in October, presents the proceedings of the International Symposium on Hemodialysis of the Annual Dialysis Conference.

Hemodialysis International considers only manuscripts that are related in any way to hemodialysis, in the form of original research, clinical experiences, case reports, review papers, letters to the editor, and editorials. Special articles such as commentaries, laudations, history of hemodialysis, clinical quizzes, and brief news notes are also considered.

Beginning August 1, 2014, all case reports accepted by the Journal will be published online only, and will not appear in the print copy of the Journal, except at the discretion of the editor. Please direct queries to the editorial office at hdieditorial@wiley.com.

Types of Articles Published by Hemodialysis International

Original Investigations present findings of a research investigation or a large series of cases. Criteria for review: validity, originality, and clinical importance. Limitations: 3,500 words (excluding abstract, references, acknowledgements, tables, and figure legends); no limit on tables or figures; no limit on authors.

Case Reports present a single case or a series of no more than 10 patients. These reports should be succinct and original and should have a single, well-defined message.Criteria for review: clinical plausibility and originality. Limitations: 1,400 words (excluding abstract, references, acknowledgements, tables, and figure legends); total of 2 figures or tables; maximum of 8 authors is generally recommended. Beginning August 1, 2014, all case reports accepted by the Journal will be published online only, and will not appear in the print copy of the Journal, except at the discretion of the editor.

Editorials are brief pieces which provide focused commentary and analysis on an article published in HI or in another journal, or on a current issue related to hemodialysis. Editorials are usually invited but may be submitted without invitation. Limitations: 1,400 words (excluding abstract, references, acknowledgements, tables, and figure legends); total of 1 figure or table; maximum 3 authors is generally recommended.

In a Few Words is a nonfiction narrative essay which gives voice to the personal experiences and stories that relate to hemodialysis. Submissions from physicians, allied health professionals, patients, or family members are welcome, and may concern the personal, ethical, or policy implications of any aspect of hemodialysis in adults and children (acute kidney injury, hemodialysis, ethics, health policy, etc.). Footnotes or references are discouraged. Limitations: 1,600 words.

Correspondence. A Letter to the Editor may be in response to an article in Hemodialysis International (HI), may concern a topic of current interest relevant to hemodialysis, or may present an abbreviated discussion of research findings. There is no guarantee that letters will be published, and they are subject to editing and abridgment without notice.

Letters responding to HI articles must be received no more than 6 weeks after the article’s date of print publication. Letters discussing topics of current interest may be submitted at any time. Limitations: 400 words (excluding (excluding abstract, references, acknowledgements, tables, and figure legends); maximum 10 references; total of 1 figure or table; maximum 3 authors.

Correspondence presenting abbreviated research findings should include an introduction, concise methods/results, and a discussion in separate paragraphs (no subheadings are used). As reports of cases do not include methods, they are not suitable for this type of correspondence. Limitations: 800 words (excluding abstract, references, acknowledgements, tables, and figure legends); maximum 10 references; total of 2 figures or tables; no limit on authors.

Review and Special Articles. A Review Article presents a comprehensive review and/or critique of the literature paired with the authors’ experience. It must be thorough and provide educational value and scientific insight. Special Articles encompass content that does not fit in the above categories and may cover any topic of interest related to hemodialysis. Both of these article types are limited to 4,000 words and must include an abstract. Review abstracts are unstructured and limited to 200 words. Special Article abstracts may be unstructured and limited to 200 words, or, if the manuscript reports original research, structured using the standard labels Background, Methods, Results, and Conclusion and limited to 300 words.

Authors of Invited Articles should query the editorial office for specific parameters, and may otherwise follow the below instructions.


Submission Policy

Papers submitted to Hemodialysis International are accepted with the understanding that the material described in the manuscript has not been previously published, except in abstract form, and that it is not simultaneously under consideration by any other journal.

For Regular Issues: Manuscripts for regular issues (January, April, July and October) must be submitted electronically directly through the Hemodialysis International online submission and peer review system: http://mc.manuscriptcentral.com/hdi.

Questions concerning the regular issues may be directed to the Journal's Editorial Office: hdieditorial@wiley.com.

For Proceedings Issues (October Supplement): If you attended and/or presented at the International Symposium on Hemodialysis (HD) held in conjunction with the Annual Dialysis Conference, you may submit a conference proceedings paper to be considered for publication in the October Proceedings Supplement Issue. 

Manuscripts for the Proceedings issue should be sent directly to the Proceedings Editorial Office: Claire Oser, Assistant to Dr. Madhukar Misra, University of Missouri, Division of Nephrology, 1 Hospital Drive CE422, Columbia, MO 65212; E-mail: oserc@health.missouri.edu or misram@health.missouri.edu.

The submission deadline for the Proceedings issue is two weeks after the Symposium. Questions concerning the Proceedings issue may be directed to the Proceedings Editorial Office. Manuscripts are peer-reviewed; the comments and recommendations for revisions will be preferentially sent by e-mail. Any manuscript declined by the Proceedings Supplement may be re-submitted to the journal for consideration in a regular issue.

Manuscript Specifications
Manuscripts must be written in English and double-spaced, 12 pt. Times New Roman font, with 1” margins. The title page, abstract and key words, text, acknowledgments, references, figure legends, and tables should be saved in a single file. Figures, supporting information, and permission/disclosure forms should be supplied as separate files. The following instructions should be adhered to:

  • Do not use the carriage return (enter) at the end of lines within a paragraph.
  • Do not use l (ell) for 1 (one), O (upper case oh) for 0 (zero) or ß (German esszett) for β (beta).
  • Use a tab, not spaces, to separate data points in tables.
  • If you use a table editor function, ensure that each data point is contained within a unique cell; do not use carriage returns within cells.

Title page. Must include all of the following elements:

  • Title of the paper
  • Running Head (short title) of less than 40 characters
  • First name, middle initial(s), and surname for each author
  • Author affiliation(s), indicated by numbers
  • Complete contact information for the corresponding author (name, mailing and email addresses)
  • Conflict of Interest Statement
  • Disclosure of grants or other funding

Structured Abstract and Keywords. Manuscripts for Original Articles require a structured abstract of no more than 300 words, presenting essential data in four paragraphs introduced by separate headings in the following order: Introduction, Methods, Findings, and Discussion. For Case Reports and Reviews, authors may submit an unstructured abstract of 300 words or less. The abstract should not include references, figures, tables, or graphs. All manuscripts are required to have 3-6 keywords suitable for indexing. Correspondence and In a Few Words narrative essays do not require abstracts, but should include keywords.

Sections and Subheadings. The text should be organized, if possible, into the following sections: Abstract, Body of Article, Acknowledgments, References, Figure Legends, Tables, Appendices. For original papers, the body of the article should have the following subheadings: Introduction, Materials and Methods, Results, Discussion

Product Names. In the text, preferentially use generic names.  For all brand names of drugs, equipment, and supplies, provide the manufacturer and location including city and country. For trademarks and registered trademarks, use appropriate symbols.

Methods Section. When reporting experiments on humans, indicate whether the procedures followed were in accord with the ethical standards of the committee on human experimentation of your institution or in accord with the Declaration of Helsinki and its revisions. If the procedures used were not approved, please explain why approval was waived or unnecessary. Include a statement about whether informed consent was obtained from subjects and, if so, whether it was oral or written. For experiments on animals, indicate whether the guidelines of the institution's committee on animal experimentation or of the National Research Council's Guide for the Care and Use of Laboratory Animals were followed.

Acknowledgements. Please include all Acknowledgements at the end of the text before the References.

References. Cite within the text using superscript numbers. At the end of the manuscript, double-space the entire reference list and arrange the references in the order in which they are first cited within the text. Include only works cited in the text. Cite personal communications and unpublished work in the text only, giving name and initials of authors and the year of writing. Spelling of author’s name and citation of dates must correspond exactly in text and reference list. Do not underscore or italicize anything (except genus and species names, and journal titles), and omit almost all punctuation (see examples). Use italics for foreign words. For references with up to 6 authors use all author names. For 7 authors or more, use et al. after third author name. Use Index Medicus abbreviations for journal titles.


Kiaii M, Kianfar C, Heidenheim AP, Lindsay RM. What “blood volume” do we dialyze? (abstract). J Am Soc Nephrol 2000; 11:277A.

Papers in journals
Twardowski ZJ, Van Stone JC, Haynie J. All currently used measurements of recirculation in blood access by chemical methods are flawed due to intradialytic disequilibrium or recirculation at low flow. Am J Kidney Dis. 1998;32(6):1046-1058.

Papers in supplements to journals
Stenvinkel P. The role of inflammation in the anaemia of endstage renal disease. Nephrol Dial Transplant. 2001; 16(Suppl 7):36-40.

Papers in supplements numbered separately
Lonnemann G. The quality of dialysate: An integrated approach. Kidney Int Suppl. 2000; 76:S112-119.

Edited books
Amerling R, Cu GA, Dubrow A, Levin NW, Osheroff RJ. Complications during hemodialysis. In: Nissenson AR, Fine RN, Gentile DE. eds. Clinical Dialysis, 3rd ed. Norwalk, CN: Appleton & Lange, 1995; 235-267.

Singh KS, Reinhold N. The Genesis of Life. Elmsford, NY: Pergamon Press, 1984.

Figure Legends. Each figure should be briefly and clearly described, with all unique abbreviations defined. Remarks such as “For explanation, see text” should be avoided. List Figure Legends after the References section.

Tables. Tables should be typed on separate sheets, numbered consecutively with Arabic numerals (e.g., Table 1, Table 1-3, etc.), and given a title. Do not use vertical lines in tables. All unique abbreviations must be defined. Do not submit images as tables; all tables must be editable text.

Figures. All photographs, graphs, and diagrams are referred to as Figures (e.g., Figure 1, Figures 1-3) and are numbered consecutively throughout in Arabic numerals. The journal accepts TIFF, JPG, and EPS file formats ONLY. Line art (charts and graphs) should have a resolution of at least 600 dpi at final size. Pictures should have a resolution of at least 300 dpi at final size. Any letters and numbers in the illustrations must be legible when the figures are reduced. More detailed information on the submission of electronic artwork can be found here.

Each figure must be uploaded as an individual file at time of manuscript submission.

If a figure has been published previously, acknowledge its source and submit written permission of the author and publisher on a permission form; the source of the figure should be included in the list of references.

Supporting Information (supplementary material). Hemodialysis International hosts Supporting Information (supplementary material) as an online-only add-on to published articles. Supporting information is submitted with a paper and must be important, ancillary information that is relevant to the parent article but cannot be included in the published version (extra tables and figures, large data sets, video clips, etc). Supporting Information should not include references or be used to submit primary material in avoidance of restrictions on article length or the permitted number of tables or figures. All Supporting Information must be referred to in the manuscript text and include a legend. Submit Supporting Information files independently of primary manuscript materials and include "supporting" or "supplementary" in file names (for example, "supp_table 1.doc"). Supporting Information will be published as submitted and will not be corrected or checked for scientific content, typographical errors or functionality. Full instructions for submitting Supporting Information can be found here.

Revisions. When submitting a revision, please include a marked copy of the manuscript showing the changes made ("track changes," colored text, or highlighting are all acceptable methods). Please also include a detailed “Response to Review” in which the authors respond to reviewer and editor comments point-by-point, so the revision can be thoroughly understood and evaluated.


  • Manuscript: Single document (title page; abstract and keywords; text; references; figure legends; tables)
  • Figures: separate uploads (individual TIFF, JPG, or EPS files)
  • Any necessary permission/disclosure forms or Supporting Information files
  • FOR REVISIONS: Marked revision and point-by-point response to review

Copyright License
Accepted articles cannot be published until the publisher has received the appropriate signed license agreement. If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log into Wiley's Author Services, where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the standard copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the standard copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

Authors of accepted manuscripts will be notified by e-mail when their page proofs are ready to download. Page proofs are produced as PDF (Portable Document Format) files and full instructions for accessing them are contained in the e-mail notification. The answered query sheet and any corrections should be returned directly to the publisher by e-mail or fax within 48 hours of receipt to allow for accommodation of authors’ corrections and to avoid publication delay.

Early View
Hemodialysis International is covered by Wiley-Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

Preprint Servers
Hemodialysis International is covered by Wiley-Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publicatio will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, etc. Authors may also post the submitted version of their manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

Data Policies
Hemodialysis International is covered by Wiley-Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publication encourages authors to share the data and other artifacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper. The journal requires that all authors cite data in the same way as article, book, and web citations in their reference list. We recommend the format proposed by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI).

Author Material Archive Policy: Please note that unless specifically requested, Wiley-Blackwell will dispose of all hard copy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible, if you have not yet done so.